Filing Flows

Filing Flows › 8-K events › Align Technology

Align Technology: entry into a material definitive agreement

Form 8-K filed Nov 6, 2026 · items 1.01, 2.03

BuybacksALIGN TECHNOLOGY ANNOUNCES $ 270 MILLION ACCELERATED STOCK REPURCHASE AGREEMENT

What the filing says

On November 5, 2026, Align Technology, Inc., a Delaware corporation (the “Company”), entered into an accelerated share repurchase agreement (the “ASR Contract”) with Goldman Sachs & Co. LLC (“Goldman Sachs”) to repurchase $270 million of the Company’s common stock authorized under the Company’s $1.0 billion stock repur

ScaleThe filing names $1.00B: about 25% of Align Technology's annual revenue ($4.06B, four times the latest quarter).

Read the filing on SEC EDGAR →

What usually followsAcross 23,525 8-Ks reporting Item 1.01 (material definitive agreement) in our universe, the stock's median move the next session was 0.0% (typical size ±1.4%, up 51% of the time); over the following 21 sessions, +1.0%. Item 2.03: 0.0% next session across 13,268. Every item ranked →

What this kind of filing means

Item 1.01 — Entry into a material definitive agreement. A material agreement is one the company considers important enough to disclose within four business days: a merger agreement, a large supply or customer contract, a credit agreement or a licence. The terms often move the company’s outlook more than a quarter’s results.

Item 2.03 — Creation of a direct financial obligation. New debt or a guarantee: the amount, the rate and the maturity set the cost of capital and the repayment wall ahead.

Align Technology at a glance

Latest quarterQ3 2026
Revenue$1.0B
Revenue Y/Y+2%
Operating margin16.7%
IndustryOrthopedic, Prosthetic & Surgical Appliances & Supplies

Align Technology, Q3 2026: revenue $1.0B (+2% year over year), operating margin 16.7%. The chart follows the revenue to costs, profit and cash.

Align Technology: every quarter, Q/Q and Y/Y, holders and guidance →

Align Technology’s other material 8-Ks

Other recent buybacks

Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.